Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Vockley

Showing results (81-90 of 293) with videos related to

Pageof 30
Sort By:
Neurology|March 4, 2018
Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathyAmel Karaa, Richard Haas, Amy Goldstein, et al.
Molecular Genetics and Metabolism|June 28, 2015
Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart reviewJerry Vockley, Deborah Marsden, Elizabeth McCracken, et al.
Journal of Inherited Metabolic Disease|January 25, 2022
Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative studyAnuradha Karunanidhi, Clinton Van't Land, Dhivyaa Rajasundaram, et al.
Molecular Genetics and Metabolism|May 3, 2005
Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidationA Michele Schuler, Barbara A Gower, Dietrich Matern, et al.
American Journal of Medical Genetics. Part A|April 18, 2024
Clinical case report of intractable paroxysmal sympathetic hyperactivity in TANGO2 deficiency disorderKaitlin Morrison, Hitoshi Koshiya, Robert Safier, et al.
Molecular Genetics and Metabolism|March 22, 2007
Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic systemEric S Goetzman, Yudong Wang, Miao He, et al.
Molecular Genetics and Metabolism|April 20, 2006
In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenaseJ Lawrence Merritt, Dietrich Matern, Jerry Vockley, et al.
Molecular Genetics and Metabolism|January 25, 2023
Resting and total energy expenditure of patients with long-chain fatty acid oxidation disorders (LC-FAODs)James P DeLany, Angela Horgan, Ashley Gregor, et al.
Clinical Nutrition ESPEN|January 25, 2021
Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin studyJerry Vockley, Nicola Longo, Megan Madden, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2026
Response to Burgard et alWendy E Smith, Barbara K Burton, Christine Brown, et al.
Pageof 30

Showing results (81-90 of 293) with videos related to

Sort By:
Pageof 30
Neurology|March 4, 2018
Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathyAmel Karaa, Richard Haas, Amy Goldstein, et al.
Molecular Genetics and Metabolism|June 28, 2015
Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart reviewJerry Vockley, Deborah Marsden, Elizabeth McCracken, et al.
Journal of Inherited Metabolic Disease|January 25, 2022
Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative studyAnuradha Karunanidhi, Clinton Van't Land, Dhivyaa Rajasundaram, et al.
Molecular Genetics and Metabolism|May 3, 2005
Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidationA Michele Schuler, Barbara A Gower, Dietrich Matern, et al.
American Journal of Medical Genetics. Part A|April 18, 2024
Clinical case report of intractable paroxysmal sympathetic hyperactivity in TANGO2 deficiency disorderKaitlin Morrison, Hitoshi Koshiya, Robert Safier, et al.
Molecular Genetics and Metabolism|March 22, 2007
Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic systemEric S Goetzman, Yudong Wang, Miao He, et al.
Molecular Genetics and Metabolism|April 20, 2006
In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenaseJ Lawrence Merritt, Dietrich Matern, Jerry Vockley, et al.
Molecular Genetics and Metabolism|January 25, 2023
Resting and total energy expenditure of patients with long-chain fatty acid oxidation disorders (LC-FAODs)James P DeLany, Angela Horgan, Ashley Gregor, et al.
Clinical Nutrition ESPEN|January 25, 2021
Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin studyJerry Vockley, Nicola Longo, Megan Madden, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2026
Response to Burgard et alWendy E Smith, Barbara K Burton, Christine Brown, et al.
Pageof 30